Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011

Kimiko Ubukata, Naoko Chiba, Miyuki Morozumi, Satoshi Iwata, Keisuke Sunakawa

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In Japan, β-lactamase-nonproducing, ampicillin-resistant organisms have been evident among Haemophilus influenzae type b (Hib) isolates since 2000, when no appropriate vaccine had been approved. We therefore performed molecular analysis of agents causing H. influenzae meningitis nationwide over the following 10 years. Some 285 institutions have participated in surveillance since 2000. The capsular type and resistance genes of 1,353 isolates and 23 cerebrospinal fluid samples from pediatric patients with meningitis we had received from 2000 to 2011 were analyzed by polymerase chain reaction. Blood and spinal fluid test results obtained when patients were admitted were examined for correlation with outcomes. Hib was found in 98.9 % of isolates. We received more than 100 Hib isolates per year until vaccination began in December 2008, when these isolates decreased, especially since establishment of a special fund to promote vaccination in November 2010. Decreased incidence among infants 7 months to 2 years old has been particularly notable. However, the rate of ampicillin-resistant organisms has increased to more than 60 % of all isolates since 2009. We received 587 replies to a questionnaire concerning outcomes, indicating 2 % mortality and 17.7 % serious morbidity. Age of 6 months or younger and presence of disseminated intravascular coagulation at admission were related to an unfavorable outcome (p < 0.05), but ampicillin resistance was not. Combination therapy with third-generation cephem and carbapenem agents was used initially for 72 % of patients. Routine immunization can prevent Hib meningitis in children.

Original languageEnglish
Pages (from-to)34-41
Number of pages8
JournalJournal of Infection and Chemotherapy
Volume19
Issue number1
DOIs
Publication statusPublished - 2013 Feb
Externally publishedYes

Fingerprint

Haemophilus influenzae type b
Haemophilus influenzae
Meningitis
Japan
Pediatrics
Ampicillin
Vaccination
Haemophilus Meningitis
Ampicillin Resistance
Carbapenems
Disseminated Intravascular Coagulation
Financial Management
Cerebrospinal Fluid
Immunization
Vaccines
Morbidity
Polymerase Chain Reaction
Mortality
Incidence
Genes

Keywords

  • Genotypic β-lactamase-nonproducing (gBLNAR)
  • Haemophilus influenzae type b (Hib)
  • Molecular epidemiology
  • Polymerase chain reaction
  • Surveillance

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011. / Ubukata, Kimiko; Chiba, Naoko; Morozumi, Miyuki; Iwata, Satoshi; Sunakawa, Keisuke.

In: Journal of Infection and Chemotherapy, Vol. 19, No. 1, 02.2013, p. 34-41.

Research output: Contribution to journalArticle

@article{ae197ff551964fa488936e2bc41c506b,
title = "Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011",
abstract = "In Japan, β-lactamase-nonproducing, ampicillin-resistant organisms have been evident among Haemophilus influenzae type b (Hib) isolates since 2000, when no appropriate vaccine had been approved. We therefore performed molecular analysis of agents causing H. influenzae meningitis nationwide over the following 10 years. Some 285 institutions have participated in surveillance since 2000. The capsular type and resistance genes of 1,353 isolates and 23 cerebrospinal fluid samples from pediatric patients with meningitis we had received from 2000 to 2011 were analyzed by polymerase chain reaction. Blood and spinal fluid test results obtained when patients were admitted were examined for correlation with outcomes. Hib was found in 98.9 {\%} of isolates. We received more than 100 Hib isolates per year until vaccination began in December 2008, when these isolates decreased, especially since establishment of a special fund to promote vaccination in November 2010. Decreased incidence among infants 7 months to 2 years old has been particularly notable. However, the rate of ampicillin-resistant organisms has increased to more than 60 {\%} of all isolates since 2009. We received 587 replies to a questionnaire concerning outcomes, indicating 2 {\%} mortality and 17.7 {\%} serious morbidity. Age of 6 months or younger and presence of disseminated intravascular coagulation at admission were related to an unfavorable outcome (p < 0.05), but ampicillin resistance was not. Combination therapy with third-generation cephem and carbapenem agents was used initially for 72 {\%} of patients. Routine immunization can prevent Hib meningitis in children.",
keywords = "Genotypic β-lactamase-nonproducing (gBLNAR), Haemophilus influenzae type b (Hib), Molecular epidemiology, Polymerase chain reaction, Surveillance",
author = "Kimiko Ubukata and Naoko Chiba and Miyuki Morozumi and Satoshi Iwata and Keisuke Sunakawa",
year = "2013",
month = "2",
doi = "10.1007/s10156-012-0448-x",
language = "English",
volume = "19",
pages = "34--41",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011

AU - Ubukata, Kimiko

AU - Chiba, Naoko

AU - Morozumi, Miyuki

AU - Iwata, Satoshi

AU - Sunakawa, Keisuke

PY - 2013/2

Y1 - 2013/2

N2 - In Japan, β-lactamase-nonproducing, ampicillin-resistant organisms have been evident among Haemophilus influenzae type b (Hib) isolates since 2000, when no appropriate vaccine had been approved. We therefore performed molecular analysis of agents causing H. influenzae meningitis nationwide over the following 10 years. Some 285 institutions have participated in surveillance since 2000. The capsular type and resistance genes of 1,353 isolates and 23 cerebrospinal fluid samples from pediatric patients with meningitis we had received from 2000 to 2011 were analyzed by polymerase chain reaction. Blood and spinal fluid test results obtained when patients were admitted were examined for correlation with outcomes. Hib was found in 98.9 % of isolates. We received more than 100 Hib isolates per year until vaccination began in December 2008, when these isolates decreased, especially since establishment of a special fund to promote vaccination in November 2010. Decreased incidence among infants 7 months to 2 years old has been particularly notable. However, the rate of ampicillin-resistant organisms has increased to more than 60 % of all isolates since 2009. We received 587 replies to a questionnaire concerning outcomes, indicating 2 % mortality and 17.7 % serious morbidity. Age of 6 months or younger and presence of disseminated intravascular coagulation at admission were related to an unfavorable outcome (p < 0.05), but ampicillin resistance was not. Combination therapy with third-generation cephem and carbapenem agents was used initially for 72 % of patients. Routine immunization can prevent Hib meningitis in children.

AB - In Japan, β-lactamase-nonproducing, ampicillin-resistant organisms have been evident among Haemophilus influenzae type b (Hib) isolates since 2000, when no appropriate vaccine had been approved. We therefore performed molecular analysis of agents causing H. influenzae meningitis nationwide over the following 10 years. Some 285 institutions have participated in surveillance since 2000. The capsular type and resistance genes of 1,353 isolates and 23 cerebrospinal fluid samples from pediatric patients with meningitis we had received from 2000 to 2011 were analyzed by polymerase chain reaction. Blood and spinal fluid test results obtained when patients were admitted were examined for correlation with outcomes. Hib was found in 98.9 % of isolates. We received more than 100 Hib isolates per year until vaccination began in December 2008, when these isolates decreased, especially since establishment of a special fund to promote vaccination in November 2010. Decreased incidence among infants 7 months to 2 years old has been particularly notable. However, the rate of ampicillin-resistant organisms has increased to more than 60 % of all isolates since 2009. We received 587 replies to a questionnaire concerning outcomes, indicating 2 % mortality and 17.7 % serious morbidity. Age of 6 months or younger and presence of disseminated intravascular coagulation at admission were related to an unfavorable outcome (p < 0.05), but ampicillin resistance was not. Combination therapy with third-generation cephem and carbapenem agents was used initially for 72 % of patients. Routine immunization can prevent Hib meningitis in children.

KW - Genotypic β-lactamase-nonproducing (gBLNAR)

KW - Haemophilus influenzae type b (Hib)

KW - Molecular epidemiology

KW - Polymerase chain reaction

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=84874111308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874111308&partnerID=8YFLogxK

U2 - 10.1007/s10156-012-0448-x

DO - 10.1007/s10156-012-0448-x

M3 - Article

C2 - 22806445

AN - SCOPUS:84874111308

VL - 19

SP - 34

EP - 41

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 1

ER -